SGD Pharma’s goal to become market leader in glass packaging

CEO Olivier Rousseau says that SGD Pharma intends to significantly grow in 2024, with a sustained and consistent approach to its strategies.

Underpinning this objective Rousseau outlines the investment achievements already notched up in 2023, which he says illustrates how SGD Pharma has paved the way for this planned growth.

He said: “The start of 2023 brought a new partnership, with the announcement of our joint venture with Corning, supported by investment from the Telangana state in India. This collaboration combined Corning’s state-of-the-art coating technology with SGD Pharma’s glass-converting expertise to manufacture Velocity Vials, Type I borosilicate glass tubing.”

Pharma packaging 

The construction of a new tubing plant officially began with a celebratory ceremony at the plant in Vemula, India in June 2023. When it’s finished, this new facility will expand pharmaceutical packaging manufacturing in India and access to the Corning Velocity Vial technology in the region.

The company’s sustainable efforts and decarbonization were key areas of progress for SGD Pharma last year and it was awarded a gold EcoVadis sustainability rating. The company made several modifications throughout the year to improve its high score for the award.

EcoVadis assesses companies in four key areas – environment, labor and human rights, sustainable procurement, and ethics – rating a company relative to its peers. High scores across the board put SGD Pharma in the top 5% of glass product manufacturers, with particularly high scores for sustainable procurement. 

Leave a Reply

Your email address will not be published. Required fields are marked *